Salem Media Group - SALM Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Salem Media Group in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SALM shares.
View SALM analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued twelve-month target prices for Salem Media Group's shares. Their SALM share price forecasts range from $5.00 to $5.00. On average, they anticipate the company's share price to reach $5.00 in the next twelve months. This suggests a possible upside of 395.0% from the stock's current price.
View analysts price targets for SALM or view top-rated stocks among Wall Street analysts.

Salem Media Group's stock was trading at $1.05 at the beginning of the year. Since then, SALM stock has decreased by 3.8% and is now trading at $1.01.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our SALM earnings forecast.

Salem Media Group, Inc. (NASDAQ:SALM) announced its quarterly earnings results on Wednesday, August, 4th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.09. The business had revenue of $63.78 million for the quarter, compared to analysts' expectations of $60.19 million. Salem Media Group had a positive trailing twelve-month return on equity of 2.67% and a negative net margin of 1.21%.

Salem Media Group issued an update on its first quarter 2023 earnings guidance on Wednesday, March, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $61.35 million-$62.60 million, compared to the consensus revenue estimate of $61.04 million.

247 employees have rated Salem Media Group Chief Executive Officer Edward G. Atsinger III on Glassdoor.com. Edward G. Atsinger III has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Salem Media Group investors own include Sirius XM (SIRI), Trevena (TRVN), OPKO Health (OPK), Advanced Micro Devices (AMD), CTI BioPharma (CTIC), TherapeuticsMD (TXMD), Arbutus Biopharma (ABUS), Adamis Pharmaceuticals (ADMP), Ampio Pharmaceuticals (AMPE) and Biocept (BIOC).

Salem Media Group trades on the NASDAQ under the ticker symbol "SALM."

Salem Media Group's stock is owned by many different institutional and retail investors. Top institutional shareholders include Verdad Advisers LP (3.20%), Dimensional Fund Advisors LP (0.57%), Renaissance Technologies LLC (0.47%), Cetera Investment Advisers (0.10%), Susquehanna International Group LLP (0.09%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Christopher J Henderson, David Evans, David P Santrella, Evan D Masyr and Stuart W Epperson.
View institutional ownership trends.

Shares of SALM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SALM stock can currently be purchased for approximately $1.01.

Salem Media Group (NASDAQ:SALM) has a market capitalization of $27.49 million and generates $266.97 million in revenue each year. The company earns $-3,240,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis.

The company employs 1,436 workers across the globe.

Salem Media Group's mailing address is 4880 SANTA ROSA ROAD, CAMARILLO CA, 93012. The official website for the company is www.salemmedia.com. The company can be reached via phone at (469) 586-0080, via email at evan@salemmedia.com, or via fax at 805-384-4520.